Pharmstandard to spin-off OTC brands

11 July 2013 - Deborah Wilkes

Archived

Pharmstandard has announced plans to acquire Singapore's Bever Pharmaceutical for US$630 million and spin-off its branded OTC business by early 2014.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: